195 related articles for article (PubMed ID: 26775906)
1. Medical Care Costs of Breast Cancer in Privately Insured Women Aged 18-44 Years.
Allaire BT; Ekwueme DU; Guy GP; Li C; Tangka FK; Trivers KF; Sabatino SA; Rodriguez JL; Trogdon JG
Am J Prev Med; 2016 Feb; 50(2):270-7. PubMed ID: 26775906
[TBL] [Abstract][Full Text] [Related]
2. Treatment Costs of Breast Cancer Among Younger Women Aged 19-44 Years Enrolled in Medicaid.
Ekwueme DU; Allaire BT; Guy GP; Arnold S; Trogdon JG
Am J Prev Med; 2016 Feb; 50(2):278-85. PubMed ID: 26775907
[TBL] [Abstract][Full Text] [Related]
3. Productivity Costs Associated With Breast Cancer Among Survivors Aged 18-44 Years.
Ekwueme DU; Trogdon JG; Khavjou OA; Guy GP
Am J Prev Med; 2016 Feb; 50(2):286-94. PubMed ID: 26775908
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer treatment costs in younger, privately insured women.
Allaire BT; Ekwueme DU; Poehler D; Thomas CC; Guy GP; Subramanian S; Trogdon JG
Breast Cancer Res Treat; 2017 Jul; 164(2):429-436. PubMed ID: 28432514
[TBL] [Abstract][Full Text] [Related]
5. Health State Utility Impact of Breast Cancer in U.S. Women Aged 18-44 Years.
Brown DS; Trogdon JG; Ekwueme DU; Chamiec-Case L; Guy GP; Tangka FK; Li C; Trivers KF; Rodriguez JL
Am J Prev Med; 2016 Feb; 50(2):255-61. PubMed ID: 26775904
[TBL] [Abstract][Full Text] [Related]
6. Breast Cancer in Young Women: Health State Utility Impacts by Race/Ethnicity.
Trogdon JG; Ekwueme DU; Chamiec-Case L; Guy GP
Am J Prev Med; 2016 Feb; 50(2):262-9. PubMed ID: 26775905
[TBL] [Abstract][Full Text] [Related]
7. Burden of venous leg ulcers in the United States.
Rice JB; Desai U; Cummings AK; Birnbaum HG; Skornicki M; Parsons N
J Med Econ; 2014 May; 17(5):347-56. PubMed ID: 24625244
[TBL] [Abstract][Full Text] [Related]
8. Healthcare cost attributable to recently-diagnosed breast cancer in a privately-insured population in the United States.
Fu AZ; Jhaveri M
J Med Econ; 2012; 15(4):688-94. PubMed ID: 22397589
[TBL] [Abstract][Full Text] [Related]
9. Estimates of the direct cost per case and overall burden of trichomoniasis for the employer-sponsored privately insured women population in the United States, 2001 to 2005.
Owusu-Edusei K; Tejani MN; Gift TL; Kent CK; Tao G
Sex Transm Dis; 2009 Jun; 36(6):395-9. PubMed ID: 19556934
[TBL] [Abstract][Full Text] [Related]
10. Estimation of Breast Cancer Incident Cases and Medical Care Costs Attributable to Alcohol Consumption Among Insured Women Aged <45 Years in the U.S.
Ekwueme DU; Allaire BT; Parish WJ; Thomas CC; Poehler D; Guy GP; Aldridge AP; Lahoti SR; Fairley TL; Trogdon JG
Am J Prev Med; 2017 Sep; 53(3S1):S47-S54. PubMed ID: 28818245
[TBL] [Abstract][Full Text] [Related]
11. Medical costs of treating breast cancer among younger Medicaid beneficiaries by stage at diagnosis.
Trogdon JG; Ekwueme DU; Poehler D; Thomas CC; Reeder-Hayes K; Allaire BT
Breast Cancer Res Treat; 2017 Nov; 166(1):207-215. PubMed ID: 28702893
[TBL] [Abstract][Full Text] [Related]
12. Medical Service Use and Charges for Cancer Care in 2018 for Privately Insured Patients Younger Than 65 Years in the US.
Zaorsky NG; Khunsriraksakul C; Acri SL; Liu DJ; Ba DM; Lin JL; Liu G; Segel JE; Drabick JJ; Mackley HB; Leslie DL
JAMA Netw Open; 2021 Oct; 4(10):e2127784. PubMed ID: 34613403
[TBL] [Abstract][Full Text] [Related]
13. Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective.
Sagar B; Lin YS; Castel LD
J Med Econ; 2017 Oct; 20(10):1018-1023. PubMed ID: 28581874
[TBL] [Abstract][Full Text] [Related]
14. Medical costs associated with metastatic breast cancer in younger, midlife, and older women.
Trogdon JG; Baggett CD; Gogate A; Reeder-Hayes KE; Rotter J; Zhou X; Ekwueme DU; Fairley TL; Wheeler SB
Breast Cancer Res Treat; 2020 Jun; 181(3):653-665. PubMed ID: 32346820
[TBL] [Abstract][Full Text] [Related]
15. Analysis of buprenorphine/naloxone dosing impact on treatment duration, resource use and costs in the treatment of opioid-dependent adults: a retrospective study of US public and private health care claims.
Khemiri A; Kharitonova E; Zah V; Ruby J; Toumi M
Postgrad Med; 2014 Sep; 126(5):113-20. PubMed ID: 25295655
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, healthcare utilization, and costs of breast cancer in a state Medicaid fee-for-service program.
Khanna R; Madhavan SS; Bhanegaonkar A; Remick SC
J Womens Health (Larchmt); 2011 May; 20(5):739-47. PubMed ID: 21417935
[TBL] [Abstract][Full Text] [Related]
17. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
18. Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US.
Cohen R; Skup M; Ozbay AB; Rizzo J; Yang M; Diener M; Chao J
J Med Econ; 2015 Jun; 18(6):447-56. PubMed ID: 25728698
[TBL] [Abstract][Full Text] [Related]
19. Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States.
Mvundura M; Amendah D; Kavanagh PL; Sprinz PG; Grosse SD
Pediatr Blood Cancer; 2009 Oct; 53(4):642-6. PubMed ID: 19492318
[TBL] [Abstract][Full Text] [Related]
20. Financial barriers to mammography: who pays out-of-pocket?
Makuc DM; Breen N; Meissner HI; Vernon SW; Cohen A
J Womens Health (Larchmt); 2007 Apr; 16(3):349-60. PubMed ID: 17439380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]